Advanced Biomedical Technologies Inc
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for… Read more
Advanced Biomedical Technologies Inc (ABMT) - Total Assets
Latest total assets as of July 2022: $383.49K USD
Based on the latest financial reports, Advanced Biomedical Technologies Inc (ABMT) holds total assets worth $383.49K USD as of July 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Advanced Biomedical Technologies Inc - Total Assets Trend (2006–2022)
This chart illustrates how Advanced Biomedical Technologies Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Advanced Biomedical Technologies Inc - Asset Composition Analysis
Current Asset Composition (October 2022)
Advanced Biomedical Technologies Inc's total assets of $383.49K consist of 73.9% current assets and 26.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.2% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $247.99K | 62.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2006–2022)
This chart illustrates how Advanced Biomedical Technologies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Advanced Biomedical Technologies Inc's current assets represent 73.9% of total assets in 2022, a decrease from 100.0% in 2006.
- Cash Position: Cash and equivalents constituted 1.2% of total assets in 2022, down from 100.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2006.
- Asset Diversification: The largest asset category is inventory at 62.7% of total assets.
Advanced Biomedical Technologies Inc Competitors by Total Assets
Key competitors of Advanced Biomedical Technologies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Advanced Biomedical Technologies Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Advanced Biomedical Technologies Inc generates 0.68x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Advanced Biomedical Technologies Inc is currently not profitable relative to its asset base.
Advanced Biomedical Technologies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.03 | 0.03 | 0.00 |
| Quick Ratio | 0.00 | 0.01 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-8.43 Million | $ -8.34 Million | $ -5.06 Million |
Advanced Biomedical Technologies Inc - Advanced Valuation Insights
This section examines the relationship between Advanced Biomedical Technologies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -11.8% |
| Total Assets | $395.70K |
| Market Capitalization | $14.18K USD |
Valuation Analysis
Below Book Valuation: The market values Advanced Biomedical Technologies Inc's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Advanced Biomedical Technologies Inc's assets decreased by 11.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Advanced Biomedical Technologies Inc (2006–2022)
The table below shows the annual total assets of Advanced Biomedical Technologies Inc from 2006 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-10-31 | $395.70K | -11.80% |
| 2021-10-31 | $448.66K | -4.38% |
| 2020-10-31 | $469.23K | +114.75% |
| 2019-10-31 | $218.50K | +53.44% |
| 2018-10-31 | $142.40K | +66.66% |
| 2017-10-31 | $85.45K | -15.16% |
| 2016-10-31 | $100.71K | -39.27% |
| 2015-10-31 | $165.83K | -23.80% |
| 2014-10-31 | $217.61K | +10.36% |
| 2013-10-31 | $197.19K | -7.86% |
| 2012-10-31 | $214.01K | +0.23% |
| 2011-10-31 | $213.51K | +112.03% |
| 2010-10-31 | $100.70K | -0.46% |
| 2009-10-31 | $101.17K | -39.70% |
| 2008-10-31 | $167.78K | +1688.70% |
| 2007-10-31 | $9.38K | +1463.33% |
| 2006-10-31 | $600.00 | -- |